| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
4.42 -0.07 (-0.02%) |
06-21 16:00 |
|
Open: |
4.49 |
Pre close: |
4.49 |
Target:
|
6.00
|
|
High: |
4.495 |
Low: |
4.36 |
Resistance:
|
5.14
5.95
|
|
Volume: |
4,978 |
Market Cap: |
82M |
Support:
|
3.83
3.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.46
 |
MACD |
MACD(12,26):
|
-0.35 |
|
MA(20): |
4.50  |
Signal(12,26,9): |
-0.43 |
|
MA(100): |
6.16 |
Stochastic Oscillator |
%K(14,3):
|
56.03 |
|
MA(250): |
6.04 |
%D(3): |
54.48 |
|
Average Volume(K) |
3-Month: |
1105
|
52-Week |
High:
|
8.59 |
|
10-Days: |
727 |
Low: |
3.66 |
|
RSI |
RSI(14):
|
39.39 |
Change(%): |
-43.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.942 |
Return on Equity (ttm) |
-66.8 |
Shares Out. (M) |
18.57 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-37.0 |
Shares Float (M) |
3.86 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.78 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
46.54 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
-1.522 |
Shares Short (K) |
37 |
|
Book Value (p.s.) |
3.050 |
EBITDA (p.s.) |
-2.322 |
P/E |
-1.50 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.45 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.21 |
P/S |
2735980032.00 |
|
Operating Margin |
-11214.61 |
Levered Free Cash Flow
(M) |
-19.52 |
P/CF |
-2.33 |
|
|
|
|
|
|
